Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Wallecha A"'
PDF file - 2785K, Figure S3. LmddA does not augment Lm-E7 antitumor activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08939757659806338be133b944eedfc4
https://doi.org/10.1158/2326-6066.22537603
https://doi.org/10.1158/2326-6066.22537603
PDF file - 312K, Figure S1. LmddA-LLO-E7 induces regression of established TC-1 tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cb8dddac7806cfbe5df53a7b8a1033
https://doi.org/10.1158/2326-6066.22537609.v1
https://doi.org/10.1158/2326-6066.22537609.v1
PDF file - 6597K, Figure S2. LmddA-LLO-E7 and Lm-E7 induce similar E7-specific CD8+ T-cell response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6339c2dad95f77f0d8705eabeb8102
https://doi.org/10.1158/2326-6066.22537606
https://doi.org/10.1158/2326-6066.22537606
Studies have shown that Listeria monocytogenes (Lm)–based vaccine expressing a fusion protein comprising truncated listeriolysin O (LLO) and human papilloma virus (HPV) E7 protein (Lm-LLO–E7) induces a decrease in regulatory T cells (Treg) and co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8477d634974552514b5344b5791edc9
https://doi.org/10.1158/2326-6066.c.6548491.v1
https://doi.org/10.1158/2326-6066.c.6548491.v1
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
Signalment and primary tumor characteristics of dogs in the historical control group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90869046e0e260742f3faeee13d7d617
https://doi.org/10.1158/1078-0432.22465167.v1
https://doi.org/10.1158/1078-0432.22465167.v1
Autor:
Vafa Shahabi, Yvonne Paterson, Sandra Rivera, Anu Wallecha, Paulo C. Maciag, Zhen-Kun Pan, Matthew M. Seavey
Purpose: The aim of this study was to efficiently design a novel vaccine for human Her-2/neu-positive (hHer-2/neu) breast cancer using the live, attenuated bacterial vector Listeria monocytogenes.Experimental Design: Three recombinant L. monocytogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5ffd61fa3ebc4ff9a32a27e069c6d4
https://doi.org/10.1158/1078-0432.c.6517480
https://doi.org/10.1158/1078-0432.c.6517480
Autor:
Vafa Shahabi, Yvonne Paterson, Sandra Rivera, Anu Wallecha, Paulo C. Maciag, Zhen-Kun Pan, Matthew M. Seavey
CCR Translation on this Article from A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a30d44261bb6b01937459c32129b21e
https://doi.org/10.1158/1078-0432.22440115
https://doi.org/10.1158/1078-0432.22440115
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
Purpose: Recombinant Listeria vaccines induce tumor-specific T-cell responses that eliminate established tumors and prevent metastatic disease in murine cancer models. We used dogs with HER2/neu+ appendicular osteosarcoma, a well-recognized spontaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e4c99c97349fb90c02df0a5cfe285e
https://doi.org/10.1158/1078-0432.c.6525942
https://doi.org/10.1158/1078-0432.c.6525942
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
ADXS31-164 does not adversely affect cardiac function.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642b0343199baeae23a44146f9f35647
https://doi.org/10.1158/1078-0432.22465182.v1
https://doi.org/10.1158/1078-0432.22465182.v1